Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01912911

Acronym

iTransmit

Enrollment

Registered

2013-07-31

Start date

2013-06-30

Completion date

2014-06-30

Last updated

2014-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

Brief summary

The investigators goal in this study is to examine the feasibility and efficacy of AliveCor iphone case monitoring device in monitoring patients after AF ablation by comparing transmissions using Alive Cor with transmissions from a traditional transtelephonic monitor (TTM). A secondary goal is to assess the ease of use of AliveCor device compared to traditional TTM system from the patient's perspective

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Male or female between \> 18 and \< 75 years of age 2. Paroxysmal or persistent atrial fibrillation 3. Scheduled to undergo an AF ablation procedure 4. Already has iPhone 4 or iPhone 4S with data plan 5. Willing to use the iPhone Alive Cor case 6. Written informed consent

Exclusion criteria

1. Unable or unwilling to use the Alive Cor case for their iPhone or iPhone 4S 2. Residing outside the United States

Design outcomes

Primary

Measure	Time frame
The proportion of AF/flutter events detected by the AliveCor device will be compared to events detected by the TTM for each episode.	3 months

Secondary

Measure	Time frame
Amount of transmissions from smartphone in comparison with traditional TTM method	3 months

Countries

United States

Outcome results